Company Details
Gmax Biopharm
3F, Building 2, 288 Qiuyi Road, Binjiang District, Hangzhou, Zhejiang, 310052, China
Overview
Gmax Biopharm International is a clinical-stage biopharmaceutical firm. The company has secured $78 million in a Series C funding round. The Series C was led by state-backed conglomerate China Merchants Group. The company disclosed the financing in a WeChat post. The article does not provide additional details on the company's products, future plans, operating metrics, or other investors.
- Total raised
- $78M
- Funding rounds
- 1
- Latest round
- Series C
- Latest activity
- Mar 2021
Industries
- Biotechnology
- Clinical Trials
- Health Care
- Product Research
Recent funding
Series C
Mar 2021
$78M